日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]

对“拷贝数和转录组学的整合为前列腺癌风险分层提供了可能:一项发现和验证队列研究”的更正[EBioMedicine 2 (9) (2015) 1133-1144]

Ross-Adams, H; Lamb, A D; Dunning, M J; Halim, S; Lindberg, J; Massie, C M; Egevad, L A; Russell, R; Ramos-Montoya, A; Vowler, S L; Sharma, N L; Kay, J; Whitaker, H; Clark, J; Hurst, R; Gnanapragasam, V J; Shah, N C; Warren, A Y; Cooper, C S; Lynch, A G; Stark, R; Mills, I G; Grönberg, H; Neal, D E

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

整合拷贝数和转录组学数据可对前列腺癌进行风险分层:一项发现和验证队列研究

Ross-Adams, H; Lamb, A D; Dunning, M J; Halim, S; Lindberg, J; Massie, C M; Egevad, L A; Russell, R; Ramos-Montoya, A; Vowler, S L; Sharma, N L; Kay, J; Whitaker, H; Clark, J; Hurst, R; Gnanapragasam, V J; Shah, N C; Warren, A Y; Cooper, C S; Lynch, A G; Stark, R; Mills, I G; Grönberg, H; Neal, D E

Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.

过氧化物酶-3在前列腺癌中过度表达,通过保护细胞免受氧化应激来促进癌细胞存活

Whitaker H C, Patel D, Howat W J, Warren A Y, Kay J D, Sangan T, Marioni J C, Mitchell J, Aldridge S, Luxton H J, Massie C, Lynch A G, Neal D E

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

中度中性粒细胞减少症联合辅助CMF方案可提高早期乳腺癌患者的生存率

Cameron, D A; Massie, C; Kerr, G; Leonard, R C F